美股A股
StockGist

Teva Pharmaceutical Industries Limited

TEVANYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and b…
$44.50+1.95%
报价 2026-11-13
市值
$51.92B
EV
$61.67B
PE (TTM)
93.0x
预期 PE (FY2026)
21.7x
52 周区间距高点 0.0%
$24.21$44.50

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Drug Manufacturers - Specialty & Generic
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
TEVATeva Pharmaceutical Industries Limited$51.92B+1.9%-0.7%55.5%93.0x30.3x39.5x
TAKTakeda Pharmaceutical Company Limited$68.13B+1.5%–59.5%79.2x9.8x–
HLNHaleon plc$40.25B+0.9%–61.8%21.8x14.3x–
ZTSZoetis Inc.$34.06B+1.0%-1.6%70.5%18.9x14.2x15.0x
VTRSViatris Inc.$23.87B+0.7%+4.8%38.8%–12.4x11.2x
NBIXNeurocrine Biosciences, Inc.$16.94B-1.2%+40.2%97.6%25.0x18.4x17.0x高增长
ELANElanco Animal Health Incorporated$13.39B+1.1%+11.2%56.9%–24.3x32.4xGARP
RDYDr. Reddy's Laboratories Limited$12.29B+0.1%–55.2%18.5x12.5x–
AMRXAmneal Pharmaceuticals, Inc.$7.45B-1.5%+6.6%42%41.2x14.1x78.8x
同行中位数––+6.6%58.2%23.4x14.2x17.0x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$4.4B$4.14B$3.98B$4.71B$4.48B$4.18B$3.89B$4.23B
Gross Margin55.5%52%49.5%56.4%51.4%50.3%48.2%50.1%
Operating Margin16.2%3.6%16.4%6.4%19.7%10.9%13.3%-0.7%
Net Income$233M$-576M$369M$480M$433M$282M$214M$-217M
Diluted EPS0.2-0.490.310.410.370.240.18-0.19
Operating Cash Flow$241M$411M$-40M$1.16B$369M$227M$-105M$575M

研究材料